BC Cancer Foundation

150 - 686 West Broadway
Vancouver, BC V5Z 1G1
President & CEO: Sarah Roth
Board Chair: Andrew Sweeney

Charitable Reg. #:11881 8434 RR0001


Ci's Star Rating is calculated based on the following independent metrics:

Unlock Charity Ratings



Audited financial statements for current and previous years available on the charity’s website.



Grade based on the charity's public reporting of the work it does and the results it achieves.



The demonstrated impact per dollar Ci calculates from available program information.


Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.



For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 69 cents are available for programs.

My anchor


About BC Cancer Foundation:

Founded in 1967, BC Cancer Foundation (BCCF) raises money for BC Cancer Agency. The foundation funds research, patient care, and major equipment purchases. BC Cancer Foundation reports distributing $33.3 million in grants in F2019, which includes $4.8 million in deferred grants paid from the prior year. 70% of grants went towards research and education, 25% towards equipment, and 5% towards patient care. The money funded six BC Cancer Centres in Kelowna, Abbotsford, Vancouver, Victoria, Surrey, and Prince George. 

BC Cancer Foundation funded over 342 researchers in F2019. Researchers at BC Cancer – Victoria are working on a new oncogene-targeted T cell therapy to improve health outcomes for lymphoid cancer patients at risk of relapse. Launched in 2018, Enhanced Pancreatic Cancer Profiling for Individualized Care is a Canada-wide research initiative on pancreatic cancer biology that sequences pancreatic tumors to develop new treatment options. BC Cancer’s flagship study in precision medicine, called Personalized Onco-Genomics (POG), looks at genomes of metastatic cancer patients to find cancer-driving genetic markers and identify individualized treatment options. As of September 2017, over 900 people are enrolled in POG, 50 types of cancer have been studied, and of cases completed to-date, 79% have produced useful information for planning tailored treatment plans.  

BCCF’s major equipment purchases in 2019 were two new PET/CT scanners for BC Cancer – Kelowna and BC Cancer – Victoria. PET/CT scanners save patients from unnecessary radiation, surgery, imaging tests and biopsies. Prior to these purchases, there were only two PET/CT scanners operating in BC (both at BC Cancer – Vancouver).  The charity is currently fundraising to replace one of the existing scanners in Vancouver.  

My anchor

Results and Impact

BC Cancer Foundation-funded researchers contributed to 524 research publications in F2019. In its F2019 impact report, The Foundation announced approval of one new cancer drug that targets 22 types of cancer. The drug’s development stems from the 1998 discovery of a gene mutation (ETV6-NTRK3) that drives connective tissue cancers. In clinical trials, the drug shrank tumors in 76% of patients to varying degrees – tumors disappeared in some and stabilized in others. The drug, named larotrectinib, is FDA-approved and licensed by Bayer Pharmaceuticals.

In June 2019, BC Cancer researchers published a paper in New England Journal of Medicine demonstrating how a modification to traditional treatment for metastatic prostate cancer led to a 52% reduction in risk of cancer progression and a 33% improvement in overall patient survival. The news release can be found here

BC Cancer – Kelowna cured 75 breast cancer patients using a new brachytherapy technique that delivers radiation treatment internally using 'seed' implants, as opposed to traditional external radiation. The report can be found here. The foundation states that BC Cancer – Kelowna is a national leader in this specialized form of radiation treatment. 

My anchor


BC Cancer Foundation is a Major 100 charity with $56.1m in donations and special events fundraising in F2019. In its F2019 annual report, the charity notes that it received one of the largest donations to cancer in Canadian history – $18.3m from an anonymous donor through Aqueduct Foundation. Administrative costs are 6% of revenues (exlcuding investment income) and fundraising costs are 25% of donations and fundraising. Per dollar donated to BCCF, 69 cents go towards grants to BC Cancer Agency, which falls within Ci’s reasonable range for overhead spending.  

Funding reserves of $163.8m include $59.5m in endowed funds. BC Cancer Foundation does not specify how much of these funds are donor-endowed. Including all endowed funds, BCCF can cover annual grants to BC Cancer Agency for 5.7 years.  

BC Cancer Foundation reported using external fundraisers in its most recent 2018 T3010 CRA filing. In F2018, BCCF paid $1m to external fundraisers that raised $2.5m. This produces an external fundraising ratio of 41% – BCCF received 59 cents of every dollar donated to external fundraisers.  

Fundraising revenues per full-time staff member were $721k in F2018. With an average full-time salary of $93k, each dollar paid in compensation brought in $8 of fundraising.  

This charity report is an update that has been sent to BC Cancer Foundation for review. Comments and edits may be forthcoming. 

Updated on July 8, 2019 by Katie Khodawandi.  

Financial Review

Financial Ratios

Fiscal year ending March
Administrative costs as % of revenues 5.7%5.8%5.8%
Fundraising costs as % of donations 25.2%25.8%27.9%
Program cost coverage (%) 574.1%554.3%387.0%

Summary Financial Statements

All figures in $000s
Donations 43,48739,02035,860
Special events 12,66110,7229,205
Investment income 6,0864,7894,834
Other income 1,4877031,854
Total revenues 63,72155,23451,753
Grants 28,53226,34834,560
Administrative costs 3,2592,9212,731
Fundraising costs 14,15912,83512,590
Cash flow from operations 17,77113,1301,872
Capital spending 000
Funding reserves 163,810146,035133,730

Note: Ci reported community awareness expenses in fundraising costs, increasing fundraising by $1.5m in F2019, $1.5m in F2018, and $1.5m in F2017. Ci adjusted for changes in amounts payable to BC Cancer, affecting grants by ($4.8m) in F2019, $721k in F2018, and $6.3m in F2017. Ci backed out amortization ($1k in F2019, $3k in F2018, and $27k in F2017) from administrative costs.  Ci reported funds held at Vancouver Foundation at fair value in funding reserves. 

Salary Information

Full-time staff: 69

Avg. Compensation $92,818

Top 10 staff salary range

$350k +
$300k - $350k
$250k - $300k
$200k - $250k
$160k - $200k
$120k - $160k
$80k - $120k
$40k - $80k
< $40k

Information from most recent CRA Charities Directorate filings for F2018

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by charity

Charity Contact

Website: www.bccancerfoundation.com
This email address is being protected from spambots. You need JavaScript enabled to view it.